Related Experiment Video
Updated: May 24, 2026

09:30
Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease
Published on: December 18, 2016
Phase-adjusted echo time (PATE)-averaging 1 H MRS: application for improved glutamine quantification at 2.89 T
Andrew P Prescot1, Todd Richards, Stephen R Dager
1Brain Institute, University of Utah, Salt Lake City, UT, USA. andrew.prescot@utah.edu
NMR in Biomedicine
|March 13, 2012
Summary
Researchers developed a new method, phase-adjusted echo time (PATE) averaging, to accurately measure glutamine levels using proton magnetic resonance spectroscopy (MRS). This technique improves the analysis of brain metabolites in psychiatric disorder research.
Area of Science:
- Neuroscience
- Biochemistry
- Medical Imaging
Background:
- Proton magnetic resonance spectroscopy (MRS) is vital for studying brain metabolism in psychiatric disorders.
- Accurate quantification of glutamate and glutamine is challenging at clinical magnetic field strengths due to overlapping signals.
Purpose of the Study:
- To develop and validate a novel post-processing method for retrieving glutamine signals from echo time (TE)-averaged (1)H MRS data.
- To improve the accuracy and reliability of glutamine quantification in vivo.
Main Methods:
- Phase-adjusted echo time (PATE) averaging: a novel post-processing technique.
- Spectral simulation to derive optimal TE-specific phase terms.
- In vivo (1)H MRS data acquisition from the human frontal lobe at 2.89 T.
- Metabolite normalization schemes for test-retest reliability assessment.
Main Results:
- PATE averaging successfully retrieves glutamine signals from TE-averaged (1)H MRS data.
- Test-retest reliability for glutamine measurement showed comparable within-subject (9-14%) and inter-subject (14-20%) variability.
- Glutamine quantification is achievable in approximately 10 minutes.
Conclusions:
- PATE averaging offers a robust method for glutamine quantification using (1)H MRS.
- The technique can be applied retrospectively to existing TE-averaged datasets.
- Improved glutamine and glutamate measurements can advance psychiatric disorder research.

